Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC DW71177 | 2241311-72-6 | 97.7% | 384.48 | 250 MG
Supplier: Medchemexpress LLC 250MGHY162088
DW71177 is a novel triazolo[4,3-a] quinoxaline-based potent and BD1-Selective BET inhibitor, which can be used for the study of acute myeloid leukemia. It is for research use only and not sold to patients.
- Novel triazolo[4,3-a] quinoxaline-based compound
- Potent and BD1-selective BET inhibitor
- Can be used for the study of acute myeloid leukemia
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?